Announcement of Completion of Final Observation Day in Phase I Clinical Trial for Allergy Vaccine
NQ Score
38/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Funpep Co., Ltd. announced the completion of the final observation day for the last patient in its Phase I clinical trial for FPP004X, an allergy vaccine under development for hay fever. Preliminary results are expected to be disclosed in the third quarter of 2026 (July-September).